ECSP003681A - Polymorphic salt - Google Patents
Polymorphic saltInfo
- Publication number
- ECSP003681A ECSP003681A ECSP003681A ECSP003681A EC SP003681 A ECSP003681 A EC SP003681A EC SP003681 A ECSP003681 A EC SP003681A EC SP003681 A ECSP003681 A EC SP003681A
- Authority
- EC
- Ecuador
- Prior art keywords
- polymorphic salt
- migraine
- prescribed
- medicine
- graph
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El presente invento trata de una forma polimórfica cristalina de un compuesto de fórmula (I) (gráfico), caracterizada por un diagrama de difracción de rayos X en polvo, obtenido al utilizar la radiación K-alfa del cobre(f = 0,15046 nm), que presenta picos principales a 9,28, 10,38, 11,37, 12,40, 16,84, 17,46, 17,53, 17,78, 17,98, 19,48, 20,70, 21,29, 21,45, 22,21, 22,64, 23,08, 25,20, y 25,79. El invento se refiere también a procedimientos para la preparación de dicha forma, a composiciones farmacéuticas que contienen la misma y a su uso en medicina, particularmente en el tratamiento de estados para los que se prescribe un agonista de recptores 5-HT, tales como, por ejemplo, la migraña.The present invention deals with a crystalline polymorphic form of a compound of formula (I) (graph), characterized by a powder X-ray diffraction diagram, obtained by using the copper's K-alpha radiation (f = 0,15046 nm ), which presents major peaks at 9.28, 10.38, 11.37, 12.40, 16.84, 17.46, 17.53, 17.78, 17.98, 19.48, 20.70 , 21.29, 21.45, 22.21, 22.64, 23.08, 25.20, and 25.79. The invention also relates to processes for the preparation of said form, pharmaceutical compositions containing the same and their use in medicine, particularly in the treatment of conditions for which a 5-HT receptor agonist is prescribed, such as, by example, migraine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY26354A UY26354A1 (en) | 2000-09-25 | 2000-09-25 | POLYMORPHIC SALT |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP003681A true ECSP003681A (en) | 2002-04-23 |
Family
ID=38812230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP003681 ECSP003681A (en) | 2000-09-25 | 2000-09-26 | Polymorphic salt |
Country Status (2)
Country | Link |
---|---|
EC (1) | ECSP003681A (en) |
UY (1) | UY26354A1 (en) |
-
2000
- 2000-09-25 UY UY26354A patent/UY26354A1/en not_active Application Discontinuation
- 2000-09-26 EC ECSP003681 patent/ECSP003681A/en unknown
Also Published As
Publication number | Publication date |
---|---|
UY26354A1 (en) | 2001-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2014306149B2 (en) | KDM1A inhibitors for the treatment of disease | |
ES2614934T3 (en) | New crystalline form III of agomelatine, its preparation process and pharmaceutical compositions containing it | |
AR029570A1 (en) | NEW GAMMA CRYSTAL FORM OF PERINDOPRIL TERBUTILAMINE SALT, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
CU23200A3 (en) | Polymorphic salt | |
JO2793B1 (en) | New Crystaline form V of Agomelatine, A process for It's Preparation and Pharmaceutical Compositions Containig it. | |
AR029571A1 (en) | NEW BETA CRYSTALLINE FORM OF PERINDOPRIL TERBUTILAMINE SALT, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
TW200736198A (en) | New crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
HU229358B1 (en) | Farnesyl protein transferase inhibitors for treating arthropathies | |
AR034124A1 (en) | ALFA CRYSTAL FORM OF PERINDOPRIL TERBUTILAMINE SALT, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
MA30464B1 (en) | NEW CRYSTALLINE VI FORM OF AGOMELATIN, ITS PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
MX2009007669A (en) | Substituted 1,3-dioxanes and their uses. | |
PE20030738A1 (en) | SUCCINIC ACID SALTS OF 5,7,14-TRIAZATETRACICLO [10.3.1.02,11.04,9] -HEXADECA-2 (11), 3,5,7,9-PENTAENE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME | |
AR029347A1 (en) | ADENINE COMPOUND, ISOGNANINE COMPOUND AND 2,6-DITIOXANTINE AS A PRECURSOR OF THE SAME, USE OF SUCH COMPOUNDS TO PREPARE A PHARMACEUTICAL COMPOSITION AND SUCH PHARMACEUTICAL COMPOSITION | |
CO2022006929A2 (en) | Crystalline form of a 7h-benzo[7]annulene-2-carboxylic acid derivative | |
FR2981933B1 (en) | OXOAZETIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS | |
PE20131327A1 (en) | DELTA CRYSTAL FORM OF PERINDOPRYL ARGININE SALT, ITS PREPARATION PROCEDURE, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
ECSP003681A (en) | Polymorphic salt | |
AR029458A1 (en) | ACTIVE COMPOUNDS IN THE GLUCOCORTICOID RECEIVER | |
ES2537792T3 (en) | Anti-amnesic compounds and pharmaceutical compositions containing them | |
TH80938B (en) | Salt | |
GB0114699D0 (en) | Organic compounds | |
Hameed | Electronic Structure of Some Chalcone Derivatives. I. Ground State Geometric Parameters and Charge Density Distributions, AM1-MO Treatment | |
TH158355A (en) | New crystalline form of benzimidazole derivatives and their method of preparation. | |
TNSN05076A1 (en) | New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it | |
PE20081757A1 (en) | [1- (4-TERC-BUTYLBENZYL) -5- (3-METHYLPHENYL) -1H-INDOL-3-IL] (OXO) ACETIC ACID POLYMORPHES |